Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Giusti

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegalyRoberto Attanasio, Roberto Baldelli, Rosario Pivonello, et al.
Thyroid Research|July 2, 2009
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiterMassimo Giusti, Mauro Caputo, Iolanda Calamia, et al.
Reviews in Endocrine & Metabolic Disorders|July 26, 2019
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegalyFederico Gatto, Claudia Campana, Francesco Cocchiara, et al.
Hormones (Athens, Greece)|December 7, 2007
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinomaMassimo Giusti, Francesca Cecoli, Carla Ghiara, et al.
Journal of Zhejiang University. Science. B|July 7, 2017
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomesMassimo Giusti, Barbara Massa, Margherita Balestra, et al.
Journal of Andrology|August 19, 2007
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery?Umberto Goglia, Carlo Toncini, Massimo Giusti, et al.
Arthritis and Rheumatism|April 16, 2002
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosusAndrea Doria, Maurizio Cutolo, Anna Ghirardello, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 9, 2018
Role of Strain Elastography and Shear-Wave Elastography in a Multiparametric Clinical Approach to Indeterminate Cytology Thyroid NodulesStefano Gay, Simone Schiaffino, Graziana Santamorena, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective StudyStefano Gay, Stefano Raffa, Anna De'Luca di Pietralata, et al.
Endocrine|May 26, 2018
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care databaseFederico Gatto, Gianluca Trifirò, Francesco Lapi, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegalyRoberto Attanasio, Roberto Baldelli, Rosario Pivonello, et al.
Thyroid Research|July 2, 2009
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiterMassimo Giusti, Mauro Caputo, Iolanda Calamia, et al.
Reviews in Endocrine & Metabolic Disorders|July 26, 2019
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegalyFederico Gatto, Claudia Campana, Francesco Cocchiara, et al.
Hormones (Athens, Greece)|December 7, 2007
Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinomaMassimo Giusti, Francesca Cecoli, Carla Ghiara, et al.
Journal of Zhejiang University. Science. B|July 7, 2017
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomesMassimo Giusti, Barbara Massa, Margherita Balestra, et al.
Journal of Andrology|August 19, 2007
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery?Umberto Goglia, Carlo Toncini, Massimo Giusti, et al.
Arthritis and Rheumatism|April 16, 2002
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosusAndrea Doria, Maurizio Cutolo, Anna Ghirardello, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 9, 2018
Role of Strain Elastography and Shear-Wave Elastography in a Multiparametric Clinical Approach to Indeterminate Cytology Thyroid NodulesStefano Gay, Simone Schiaffino, Graziana Santamorena, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective StudyStefano Gay, Stefano Raffa, Anna De'Luca di Pietralata, et al.
Endocrine|May 26, 2018
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care databaseFederico Gatto, Gianluca Trifirò, Francesco Lapi, et al.
Pageof 9